Follow-The-Filings

Security

AMLX

Amylyx Pharmaceuticals Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

7 owners 2 exits max 0.0% (Dmitry Balyasny - Balyasn...)

grid → activity →
owners 7
max % 0.0%
tracked value $98M
qoq A 5 R 1 E 2

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% Add +0.01 pp 1,107,271 $15M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.01 pp 344,401 $4M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 5,804,912 $70M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 411,532 $6M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce 0.00 pp 106,535 $1M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Add 0.00 pp 74,230 $1M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 29,089 $404 hist
Renaissance Technologies LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 192,500 $2M hist
Israel Englander - Millennium Management LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 46,455 $561 hist

7 current · 2 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $380.79M $87.37M $0.00
Gross profit * $355.34M $81.42M $0.00
Gross margin * 93.3% 93.2% —
Net income $49.27M -$301.74M -$144.74M
Net margin * 12.9% -345.4% —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $464.67M $189.43M $323.67M
Total non-current assets * $52.79M $4.2M $8.97M
Total assets $517.45M $193.63M $332.64M
Total current liabilities $82.04M $28.41M $22.69M
Total non-current liabilities * $1.98M $463,000 $4.7M
Total equity $433.43M $164.76M $305.26M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $11.92M -$167.65M -$123.34M
Cash from investing $92.05M $75.65M $14.04M
Cash from financing $3.54M $348,000 $257.03M
Net change in cash $107.68M -$92.08M $148.8M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders